High Incidence Rate of DVT/PE across the Globe is Expected to Fuel the Anticoagulants Market in Future REQUEST FOR SAMPLE REPORT Buy Now Request For sample Report × Report Title Name Email Designation Phone No Comapny Name Comapny URL Country -- Please Select Your Country -- Afganistan Africa Albania Algeria Andorra Angola Anguilla Antigua and Barbuda Argentina Armenia Aruba Asia Australasia Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bonaire Bosnia Herzegovina Botswana Brazil BRICS British Virgin Islands Brunei Darussalam Bulgaria Burkina Faso Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Central and South America Chad Chile China Colombia Comoros Congo Costa Rica Cote d'Ivoire Croatia Cuba Curacao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Europe European Union Falkland Islands Faroe Islands Fiji Finland France French Guiana French Polynesia Gabon Gambia Georgia Germany Ghana Gibraltar Global Great Britain Greece Greenland Grenada Guadeloupe Guam Guatemala Guerney & Alderney Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Ivory Coast Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kosovo Kuwait Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Man (Island of) Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia Middle East Minnesota Moldova Monaco Mongolia Monserrat Montenegro Morocco Morroco Mozambique Myanmar Namibia Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue North America North Korea Norway Oman Pakistan Palau Palestine Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Qatar Reunion Romania Russia Rwanda Saint Helena Saint Lucia Saint Martin Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa Samoa (American) San Marino Sao Tome and Principe Saudi Arabia Scandinavia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten Slovakia Slovenia Solomon (Islands) Somalia South Africa South Korea South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syria Taiwan Tajikistan Tanzania Thailand Timor Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Vatican City Venezuela Vietnam Virgin Islands Western Sahara Yemen Zambia Zimbabwe Requirement Submit Future growth of global anticoagulants market is expected to be led by high incidence rate of DVT/PE and other cardiac diseases across the globe. Bayer AG, Sanofi, Janssen Pharmaceuticals, Boehringer Ingelheim, Pfizer, Inc. and Bristol-Myers Squibb are major players operating in the market. Bayer AG is observed as the dominating players among owing to high demand for Xarelto. North America region was the major revenue contributor in anticoagulants market in 2015 owing to the high prevalence, awareness about the disease and economic stability of the people to undergo expensive treatment options. Ken Research announced its latest publication on “Global Anticoagulants Market Outlook to 2020 – Demand for Patented NOACs with Prevalence of Cardiac Diseases to Drive Global Market” provides a comprehensive analysis of the anticoagulants market. The report includes the cumulative revenue generated by the market players from the sales of anticoagulants, including both generic and patented drugs at manufacturer’s price and market share contributed by the sales of heparin, NOACs, Vitamin K Antagonists, and Injectable Direct Inhibitors in the total anticoagulants market. Further, the market in the study is differentiated on the basis of route of administration into oral and injectable. The market is also segmented by four geographical regions across the globe – North America, Europe, Asia Pacific, and Rest of the World. Detailed snapshot on key regions of the Market which includes North America, Europe, and Asia Pacific is included in the report to elucidate facts about the market in detail. The study also highlights the detailed information about major drug manufacturers in the global anticoagulants market and their respective shares by revenue in 2015. Analysis on patented drugs available in the market and their approval procedure, timeline, and expected expiries is provided in report to assist new entrants in understanding the market before investing in the market. Various marketing analysis factors such as trends and developments and Porter’s five forces analysis are also added in the study for clear understanding about the factors responsible for present scenario of the market. The future analysis of overall global anticoagulants market has also been discussed along with recommendations from analyst view. High incidence rate of DVT (deep vein thrombosis) and PE (pulmonary embolism) globally, leading to large patient population and anticoagulants being an important part of the first-line treatment has observed a high growth in between 2013 and 2015. It has been estimated that approximately 900,000 people get affected by DVT/PE in the US every year. Similarly, it has been observed that there were 2.300 deaths in UK due to PE in year 2012, which accounts for 2% of total deaths in UK. Moreover, 47,594 cases of PE were reported in UK in one year of period in between 2013 and 2014. The annual incidence of PE is also observed high in Scandinavia and Australia with estimated value of 1.8 cases per 1,000 population and 0.31 cases per 1,000 people respectively. The number is even expected to increase during the forecast period, which will consequently result in high demand for anticoagulants for treatment purpose, hence driving the market. “In order to penetrate into the growing anticoagulants market, the market players could plan to invest in emerging economies especially India and China. The companies should expand their marketing and sales initiatives in these countries for better distribution and margins. Bayer entered into joint venture with Zydus to market Xarelto in India successfully. Other players can also follow same approach.” according to Research Analyst, Ken Research. Key Topics Covered in the Report: The market size of Global Anticoagulants Market Market segmentation of Global Anticoagulants Market By Type – Heparins, Novel Oral Anticoagulants, Injectable Direct Inhibitors, and Vitamin K Antagonists; By Route of Administration – Oral and Injectables; By Geographical Regions – North America, Europe, Asia Pacific, and Rest of the World Snapshot on North America Anticoagulants Market Snapshot on Europe Anticoagulants Market Snapshot on Asia Pacific Anticoagulants Market Porter’s Five Forces Analysis for Global Anticoagulants Market Trends and Developments in Global Anticoagulants Market NOACs Drug Approval Timeline NOACs Patent Expiries Competitive landscape and Detailed Company Profiles of the major market players Future Outlook and Projections of Global Anticoagulants Market Analyst Recommendations Macro-economic Factors Impacting the Global Anticoagulants Market Key Products Mentioned in the Report Xarelto Eliquis Lixiana/Savaysa Pradaxa Lovenox Arixtra Fragmin Warfarin Key Market Players Covered in the Report: Pfizer, Inc. Sanofi Boehringer Ingelheim Bayer AG Bristol-Myers Squibb Company Daichi Sankyo Company, Limited Janssen Pharmaceuticals For more information about the publication, refer to below link: https://www.kenresearch.com/healthcare/pharmaceuticals/global-anticoagulants-market-report/77871-91.html Contact Us Ken Research Ankur Gupta, Head Marketing & Communications Ankur@kenresearch.com +91-9015378249 Tags: Anticoagulant Market, Anticoagulant Market Analysis, Anticoagulants Drugs Market, Anticoagulants Market share, Anticoagulants Market Size, Antithrombotic Drugs Market Trends, Bayer Market Share Anticoagulants, Competition Bristol-Myers Squibb Anticoagulants, Eliquis Revenue Anticoagulants, Fragmin Sales Data, Global Anticoagulants Market, Heparin Penetration United States, Incidence Rate DVT PE Global, Industry Forecast Low Molecular Weight Heparin, Janssen Pharmaceuticals Sales Anticoagulants, Lovenox Sales Global, Market Share Pfizer Xarelto Sales Bayer, Market Trends Direct Inhibition Inhibitors, NOACs Drugs Market Global, North America Heparin Market, Novel Oral Anticoagulants Market Growth, Pradaxa Competition in Anticoagulants, Sales Performance Arixtra, Sanofi Market Revenue Anticoagulants, Unfractionated Heparin Market Growth, US Death Rate due to DVT, Vitamin K Antagonists Market, Warfarin Performance Revenue